Adding Silo Pharma (SILO) $3.50 to Watch List.
Look What We Found!
We launched the Psychedelic Stock Review a little more than a year ago and decided to take a wait-and-see attitude.
We...
Silo Pharma (SILO) Issues Letter to Shareholders
Silo Pharma Issues Letter to Shareholders Detailing Progress on Pipeline Assets Combining Traditional Therapeutics with Psychedelic Medicine
LIVE QUOTE
ENGLEWOOD CLIFFS, NJ, Dec. 01, 2022 (GLOBE...
Provention Bio (PRVB) Gains 26% Last Week.
We're up 106% From Adding to the 2022 Watch List Last July. And up 26% a Week After Urging Holders to Calm Down, Let's...
FDA Approves Most Expensive Drug Ever, @ $3.5 Million-Per-Dose, from uniQure (QURE).
Important to note, the FDA didn't approve the price, they approved the drug. It was priced afterwards. Second item it is a one-time treatment.
FDA...
FDA Approval for Provention Bio (PRVB).
Re-cork the Champagne!
We were contemplating (dreaming) about an opening price over $12, and then a drift up towards $20, sometime during 2023. But no,...
Adding Ardelyx (ARDX) $1.57 to Watch List.
FDA Advisory Committee Says Go Forth Young Man!
While we hadn't previously owned Ardelyx, nor are they a client - there are a number of...
Provention Biosciences (PRVB) Enters the Danger Zone.
Chart Looks Beautiful - But Nervous is why, we use soft and dry.
LIVE QUOTE
We'll be short and sweet. We make no prediction as for...
Progressive Care (RXMD) Conference Call.
Progressive Care Announces Shareholder Conference Call and Business Update on November 14, 2022
MIAMI, FL, Nov. 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Progressive Care Inc....
VERU (VERU) $6.66, Goes Poof.
Veru Provides Update on FDA Advisory Committee Meeting
Market Cap Plunges from $1.9 Billion to $540 Million.
"In the long history of drug trials for patients...
Progressive Care Launches Native Remote Patient Monitoring Mobile App .
Progressive Care Launches Native Remote Patient Monitoring Mobile App and Physician Portal to Remotely Manage Chronic and Transitional Care
MIAMI, FL, Nov. 01, 2022 (GLOBE...















